Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Archives of Toxicology|January 20, 2016
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinomaLucia Pellé, Monica Cipollini, Roman Tremmel, et al.
Cell Death & Disease|October 16, 2025
Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killingFrancesca Barberini, Riccardo Pietroni, Simone Ielpo, et al.
International Journal of Molecular Sciences|July 15, 2020
EIF4G1 and RAN as Possible Drivers for Malignant Pleural MesotheliomaIrene Dell'Anno, Marcella Barbarino, Elisa Barone, et al.
Immunology Letters|September 20, 2024
NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advancesMarco Greppi, Fabiana De Franco, Valentina Obino, et al.
Oncoimmunology|February 5, 2019
Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumorsRenata Boldrini, Maria Debora De Pasquale, Ombretta Melaiu, et al.
Mutation Research|March 17, 2015
Expression status of candidate genes in mesothelioma tissues and cell linesOmbretta Melaiu, Erika Melissari, Luciano Mutti, et al.
Genes & Cancer|April 25, 2017
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell linesOmbretta Melaiu, Calogerina Catalano, Chiara De Santi, et al.
Scientific Reports|June 11, 2017
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolismChiara De Santi, Ombretta Melaiu, Alessandra Bonotti, et al.
Occupational and Environmental Medicine|March 27, 2017
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individualsChiara De Santi, Perla Pucci, Alessandra Bonotti, et al.
Cancer Treatment Reviews|September 29, 2024
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancerFederico Rebaudi, Fabiana De Franco, Rayan Goda, et al.
Pageof 7